Abstract There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders
Clostridium butyricum (1 Billion CFU) Clostridium butyricum is a spore-forming probiotic strain with documented use in clinical and commercial settings, particularly in Asian and European markets
6a) or macrophages (IBA1+, Fig
It is meant to be used together with a lifestyle therapy regimen involving a reduced calorie diet and increased physical activity
10.1186/1471-230X-13-175 BMC Gastroenterol
Inappropriate storage conditions, such as prolonged exposure to sunlight, high temperature, humidity, and freezing conditions, may result in alterations to the product